Canaccord Genuity Reiterates a 'Buy' on Amarin Corp (AMRN); Anchor Data Drops and Crushes It
Tweet
Share
E-mailGet Alerts AMRN Hot Sheet
Price: $14.15 +2.24%
Rating Summary:
6 Buy, 12 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 10 | New: 18
Rating Summary:
6 Buy, 12 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 10 | New: 18
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on Amarin Corporation (NASDAQ: AMRN), raises PT from $11 to $18.
Canaccord analyst, Ritu Baral, says, "Statistically significant triglyceride and LDL lowering with high dose above expectations - Reiterate BUY, raising target on larger AMR101 commercial potential and impressive ANCHOR results this morning. AMR101 is AMRN’s purified EPA omega-3 drug for high triglycerides. We think AMRN may submit the AMR101 NDA for very high triglycerides in Q3/11 and get approval in H1/12. We are raising our pNPV-based target to $18, based higher projections for peak AMR101 sales in mixed dyslipidemia."
For more ratings news on Amarin Corporation click here and for the rating history of Amarin Corporation click here.
Shares of Amarin Corporation closed at $8.77 yesterday.
Canaccord analyst, Ritu Baral, says, "Statistically significant triglyceride and LDL lowering with high dose above expectations - Reiterate BUY, raising target on larger AMR101 commercial potential and impressive ANCHOR results this morning. AMR101 is AMRN’s purified EPA omega-3 drug for high triglycerides. We think AMRN may submit the AMR101 NDA for very high triglycerides in Q3/11 and get approval in H1/12. We are raising our pNPV-based target to $18, based higher projections for peak AMR101 sales in mixed dyslipidemia."
For more ratings news on Amarin Corporation click here and for the rating history of Amarin Corporation click here.
Shares of Amarin Corporation closed at $8.77 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Calumet Specialty Products Partners (CLMT) PT Raised to $47 at UBS
- Amarin to present REDUCE-IT analyses at ESC Congress 2026
- DA Davidson Starts QXO Inc (QXO) at Neutral
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
